CLINICAL_TRIALS
ClinicalTrials.gov record update
A Randomized, Multicenter, Double Blinded Study Comparing the Safety and Efficacy of Pegasys® 180 ug Plus Copegus® 1000 or 1200 mg to the Currently Approved Combination of Pegasys® 180 ug Plus Copegus® 800 mg in Interferon-naïve Patients With Chronic Hepatitis C Genotype 1 Virus Infection and HIV-1
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00353418
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:03.298212+00:00
- Published At
- 2010-06-15T00:00:00+00:00
- Record Updated At
- 2010-08-03
- Results Posted At
- 2010-06-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Hepatitis C, Chronic"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2010-08-03"- protocolSection.identificationModule.nctId
"NCT00353418"- protocolSection.identificationModule.officialTitle
"A Randomized, Multicenter, Double Blinded Study Comparing the Safety and Efficacy of Pegasys\u00ae 180 ug Plus Copegus\u00ae 1000 or 1200 mg to the Currently Approved Combination of Pegasys\u00ae 180 ug Plus Copegus\u00ae 800 mg in Interferon-na\u00efve Patients With Chronic Hepatitis C Genotype 1 Virus Infection and HIV-1"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2010-06-15"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.